Pharmaceutical composition comprising aleglitazar

Details for Australian Patent Application No. 2010206249 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Glomme, Alexander; Wojtera, Paul

Agent Spruson & Ferguson

Pub. Number AU-A-2010206249

PCT Pub. Number WO2010/084066

Priority 09151254.1 23.01.09 EP

Filing date 13 January 2010

Wipo publication date 29 July 2010

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

Event Publications

30 June 2011 PCT application entered the National Phase

  PCT publication WO2010/084066 Priority application(s): WO2010/084066

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010206281-A method and system using zeta potential altering compositions as aggregating reagents for sand control

2010206233-Quinazolinone derivatives useful as vanilloid antagonists